New government coalition plans AMNOG, pricing and other reforms
The new government in Germany is formed as a coalition of the three parties, SDP, FDP and the Green Party. At the
Tag: AMNOG process
The biggest SHI fund, the AOK, proposes an end to free pricing in Germany
Currently, free pricing of products with a new chemical entity (NCE) applies in the first year. This means, at the time of
Reimbursement price and discounts – Drug prices in Germany
You might be familiar with the price negotiations to derive the reimbursement price, but this does not always reflect the final, real-world
Why did the G-BA assess Trimbow now?
Trimbow was launched onto the German market in 2017. So why did the G-BA assess its benefit now? You likely know that
Pricing in Germany: How is the reimbursed price of a drug set?
At the time of launch in the German market, pharmaceutical companies are free to set the price for their product with a